{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:09:35Z","timestamp":1767852575674,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.acuroe.2025.501788","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T11:00:38Z","timestamp":1748084438000},"page":"501788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparing Prostatype P-score and traditional risk models for predicting prostate cancer outcomes in Spain"],"prefix":"10.1016","volume":"49","author":[{"given":"P.","family":"Gonz\u00e1lez-Peramato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"\u00c1lvarez-Maestro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Heredia-Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mendiola Sabio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Linares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"\u00c1lvarez-Ossorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"L\u00f3pez Alcina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"V\u00e1zquez Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Aller Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2025.501788_bib0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"issue":"11 Pt B","key":"10.1016\/j.acuroe.2025.501788_bib0010","first-page":"E701","article-title":"Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010","volume":"110","author":"C\u00f3zar","year":"2012","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.acuroe.2025.501788_bib0015","article-title":"Radical prostatectomy versus deferred treatment for localised prostate cancer","volume":"6","author":"Vernooij","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"10.1016\/j.acuroe.2025.501788_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.acuroe.2025.501788_bib0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.euo.2020.03.002","article-title":"Intermediate-risk prostate cancer: stratification and management","volume":"3","author":"Preisser","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"11","key":"10.1016\/j.acuroe.2025.501788_bib0030","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D\u2019Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.acuroe.2025.501788_bib0035","unstructured":"European Association of Urology, Guidelines, Prostate cancer. Accessed April 10, 2024. https:\/\/uroweb.org\/guidelines\/prostate-cancer."},{"issue":"3","key":"10.1016\/j.acuroe.2025.501788_bib0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"NCCN Guidelines\u00ae Insights: Prostate Cancer, Version 3. 2024","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.acuroe.2025.501788_bib0045","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.urolonc.2023.03.004","article-title":"Financial hardship and psychosocial well-being and quality of life among prostate cancer survivors in the United States","volume":"41","author":"Yabroff","year":"2023","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.acuroe.2025.501788_bib0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/pcan.2013.57","article-title":"An expression signature at diagnosis to estimate prostate cancer patients\u2019 overall survival","volume":"17","author":"Peng","year":"2014","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.acuroe.2025.501788_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145545","article-title":"Improving the prediction of prostate cancer overall survival by supplementing readily available clinical data with gene expression levels of IGFBP3 and F3 in formalin-fixed paraffin embedded core needle biopsy material","volume":"11","author":"Peng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.acuroe.2025.501788_bib0060","first-page":"203","article-title":"A Novel Risk Score (P-score) based on a three-gene signature, for estimating the risk of prostate cancer-specific mortality","volume":"14","author":"S\u00f6derdahl","year":"2022","journal-title":"Res Rep Urol"},{"issue":"3","key":"10.1016\/j.acuroe.2025.501788_bib0065","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033688","article-title":"Metastases in prostate cancer","volume":"9","author":"Manna","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9","key":"10.1016\/j.acuroe.2025.501788_bib0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.34622","article-title":"Incidence, prevalence, and survival of prostate cancer in the UK","volume":"7","author":"Tan","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.acuroe.2025.501788_bib0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/biom11050621","article-title":"Overcoming the challenges of high quality RNA extraction from core needle biopsy","volume":"11","author":"Locy","year":"2021","journal-title":"Biomolecules"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578625001052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578625001052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:17:18Z","timestamp":1753355838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578625001052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2173578625001052"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2025.501788","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing Prostatype P-score and traditional risk models for predicting prostate cancer outcomes in Spain","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2025.501788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2025.501788","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of AEU. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501788"}}